4.1 Article

Fecal microbiota transplantation: A 'How-To' guide for nurses

期刊

COLLEGIAN
卷 22, 期 4, 页码 445-451

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.colegn.2014.08.002

关键词

Fecal microbiota transplantation; Clostridium difficile; Microbiota

类别

向作者/读者索取更多资源

Fecal microbiota transplantation is emerging as one of the most exciting treatments of this century. Rarely has one treatment provided the opportunity to treat a myriad of diseases, not only within the gastrointestinal tract but also in extra-intestinal organs; such is the power of the gastrointestinal microbiota to modulate the immune system and eradicate infections, even where antibiotics have previously failed. The demand for this therapy, both among patients and physicians, is increasing, and a search of the literature reveals numerous reviews, case reports and discussion on the topic. However, to date, much of the literature addresses the procedure from a physician's point of view, and can therefore be lacking in practical detail. As nurses are often the 'unsung heroes' of the procedure, it is timely to address the subject from a nursing perspective. (C) 2014 Australian College of Nursing Ltd. Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Gastroenterology & Hepatology

Comment on 2018 ACG Clinical Guideline: Antibiotics in Crohn's Disease

William Chamberlin, Thomas Borody

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Sudarshan Paramsothy, Shaun Nielsen, Michael A. Kamm, Nandan P. Deshpande, Jeremiah J. Faith, Jose C. Clemente, Ramesh Paramsothy, Alissa J. Walsh, Johan van den Bogaerde, Douglas Samuel, Rupert W. L. Leong, Susan Connor, Watson Ng, Enmoore Lin, Thomas J. Borody, Marc R. Wilkins, Jean-Frederic Colombel, Hazel M. Mitchell, Nadeem O. Kaakoush

GASTROENTEROLOGY (2019)

Article Microbiology

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing Glade 2 ribotype 251 strain

Michael C. Wehrhahn, Caitlin Keighley, Jelica Kurtovic, Daniel R. Knight, Stacey Hong, Melanie L. Hutton, Dena Lyras, Qinning Wang, Rupert Leong, Tom Borody, Michael Edye, Thomas V. Riley

ANAEROBE (2019)

Article Gastroenterology & Hepatology

Microbiota transplant therapy and autism: lessons for the clinic

James B. Adams, Thomas J. Borody, Dae-Wook Kang, Alexander Khoruts, Rosa Krajmalnik-Brown, Michael J. Sadowsky

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Letter Gastroenterology & Hepatology

Oral fecal microbiota transplant for recurrent Clostridium difficile in pediatric autoimmune enteropathy

Harveen Singh, Lindsey Ross, Harriet Smith, Thomas J. Borody, Daniel A. Lemberg

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice

Craig Haifer, Colleen R. Kelly, Sudarshan Paramsothy, David Andresen, Lito E. Papanicolas, Genevieve L. McKew, Thomas J. Borody, Michael Kamm, Samuel P. Costello, Jane M. Andrews, Jakob Begun, Hiu Tat Chan, Susan Connor, Simon Ghaly, Paul D. R. Johnson, Daniel A. Lemberg, Ramesh Paramsothy, Andrew Redmond, Harsha Sheorey, David van der Poorten, Rupert W. Leong

Article Microbiology

Targeted Combination Antibiotic Therapy Induces Remission in Treatment-Naive Crohn's Disease: A Case Series

Gaurav Agrawal, Annabel Clancy, Rijata Sharma, Roy Huynh, Sanjay Ramrakha, Thomas Borody

MICROORGANISMS (2020)

Article Microbiology

Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis

Irina Leonardi, Sudarshan Paramsothy, Itai Doron, Alexa Semon, Nadeem O. Kaakoush, Jose C. Clemente, Jeremiah J. Faith, Thomas J. Borody, Hazel M. Mitchell, Jean-Frederic Colombel, Michael A. Kamm, Iliyan D. Iliev

CELL HOST & MICROBE (2020)

Article Gastroenterology & Hepatology

Profound remission in Crohn's disease requiring no further treatment for 3-23 years: a case series

Gaurav Agrawal, Annabel Clancy, Roy Huynh, Thomas Borody

GUT PATHOGENS (2020)

Article Microbiology

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection

Craig Haifer, Sudarshan Paramsothy, Thomas J. Borody, Annabel Clancy, Rupert W. Leong, Nadeem O. Kaakoush

Summary: Oral lyophilized fecal microbiota transplantation (FMT) is effective in treating Clostridioides difficile infection (CDI), improving microbial diversity and resulting in durable engraftment up to 6 months post-treatment, with better efficacy observed in primary CDI compared to recurrent cases. Changes in bacterial and fungal communities are associated with therapy outcomes.

MSYSTEMS (2021)

Article Gastroenterology & Hepatology

Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study

Anoja W. Gunaratne, Harrison Hamblin, Annabel Clancy, Aleja Jane Marie C. Magat, Marie Vic M. Dawson, Jeffrey Tu, Thomas J. Borody

Summary: The study investigated the efficacy and safety of vonoprazan-containing antibiotic combination therapies in eradicating H. pylori infection in an Australian setting. Results showed a high eradication rate of 97% overall, with 100% efficacy in treatment-naive patients and 91% efficacy in those who had previously failed eradication treatment. Further studies are needed to optimize treatment regimens involving multiple antibiotics.

HELICOBACTER (2021)

Article Microbiology

Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients

Sabine Hazan, Sonya Dave, Anoja W. Gunaratne, Sibasish Dolai, Robert L. Clancy, Peter A. McCullough, Thomas J. Borody

Summary: This study examined the effectiveness of a combination therapy consisting of ivermectin, doxycycline, zinc, and vitamins D and C in treating COVID-19. The results showed that all patients experienced symptom relief and improved oxygen saturation. The study suggests that this treatment approach is safe and effective for outpatient cases with moderate to severe symptoms.

FUTURE MICROBIOLOGY (2022)

Letter Microbiology

Letter in reply: more power to ivermectin multidrug therapy

Sabine Hazan, Sonya Dave, Thomas J. Borody, Peter A. McCullough

FUTURE MICROBIOLOGY (2022)

Article Gastroenterology & Hepatology

Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience

Harrison Hamblin, Anoja W. Gunaratne, Annabel Clancy, Denise Pilarinos, Antoinette LeBusque, Marie Vic M. Dawson, Thomas J. Borody

Summary: This study evaluated the safety and efficacy of a six-month fecal microbiota transplantation (FMT) treatment protocol in patients with irritable bowel syndrome (IBS). The results showed that this treatment was able to alleviate IBS symptoms in the short- and long-term, while improving the quality of life for patients.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2022)

Article Microbiology

Metagenomic Hi-C of a Healthy Human Fecal Microbiome Transplant Donor

Matthew Z. DeMaere, Michael Y. Z. Liu, Enmoore Lin, Steven P. Djordjevic, Ian G. Charles, Paul Worden, Catherine M. Burke, Leigh G. Monahan, Melissa Gardiner, Thomas J. Borody, Aaron E. Darling

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2020)

暂无数据